Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
10/2009
10/06/2009US7598383 mitogen activated protein kinase inhibitors; 4-(2-fluoro-4-methylphenylamino)-1,3-dimethyl-6,7-dihydro-1H-pyrrolo[3,4-b]pyridine-2,5-dione; used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals
10/06/2009US7598379 Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthines
10/06/2009US7598260 CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
10/06/2009US7598259 mGluR1 antagonists as therapeutic agents
10/06/2009US7598255 Pyrimidine compounds as serotonin receptor modulators
10/06/2009US7598236 Diazabicyclic central nervous system active agents
10/06/2009CA2402431C 1,2,3,4-tetrahydroisoquinoline derivatives
10/06/2009CA2301377C N-aroylphenylalanine derivatives
10/01/2009WO2009121042A1 Quinazoline derivatives and methods of treatment
10/01/2009WO2009118598A1 Process for the manufacture of rosuvastatin calcium with high purity
10/01/2009WO2009118384A1 Quinazolinone derivatives as tubulin polymerization inhibitors
10/01/2009WO2009117985A1 Pirinixic acid derivatives as prostglandin e2 synthesis inhibitors for treating inflammatory diseases
10/01/2009WO2009117899A1 The polymorphs of 4-anilinoquinazoline derivatives, the preparation methods and uses thereof
10/01/2009WO2009080638A3 Sulfamides as zap-70 inhibitors
10/01/2009WO2009060835A8 Novel ubiquilin-binding small molecule
10/01/2009US20090247555 5,7-Disubstituted[1,3]Thiazolo[4,5-D]Pyrimidin-2(3H)-One Derivatives 258
10/01/2009US20090247553 Highly Pure Paliperidone or a Pharmaceutically Acceptable Salt Thereof Substantially Free of Keto Impurity
10/01/2009US20090247534 New compounds
10/01/2009US20090247524 HSP90 Inhibitor
10/01/2009US20090247519 Amino-ethyl-amino-aryl (aeaa) compounds and their use
10/01/2009US20090247509 for treating central nervous system disorders such as psychological disorders, drug dependence and abuse, dyskinesia, dementia, anxiety disorders, sleep disorders and mood disorders
10/01/2009US20090247506 Antibacterial agents
10/01/2009CA2716088A1 Quinazolinone derivatives as tubulin polymerization inhibitors
09/2009
09/30/2009EP2105435A1 Hydrazone derivative
09/30/2009CN101547910A Crystalline erlotinib
09/30/2009CN101544609A Crystallization form of 4-anilinoquinazoline derivatives
09/29/2009US7595501 Electroluminescent iridium compounds with fluorinated phenylpryidines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
09/29/2009US7595400 Synthesis of antitumor agents including camptothecin derivative 9-ethyl-9-hydroxy-1-pentyl-1H,12H-pyrano[3'',4'':6',7']-indolizino[1',2':6,5]pyrido[4,3,2-de]quinazoline-10,13(9H,15H)-dione
09/29/2009US7595343 Inhibitors of histone deacetylase
09/29/2009US7595332 Such as N-(4-tert-butylphenyl)-4-(2-pyridinyl)benzamide for treatment of urinary incontinence, pain, inflammatory thermal hyperalgesia, and/or bladder overactivity
09/29/2009US7595326 1-[4-(5-Bromopyrimidin-2-ylsulfanyl)phenyl]-3-(2-nitrobenzoyl)-urea; antiproliferative, water soluble compound with high bioavailability
09/29/2009US7595323 N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
09/29/2009US7595317 Antiarthritic agents; rheumatoid and osteoarthritis; corneal, epidermal, or gastric ulceration; tumor metastasis or invasion; periodontal disease; and bone disease; 4-[(2-methyl-4-quinolinyl)methoxy]-N-(1,3,5-trioxo-2,4-diazaspiro[5.5]undec-7-yl)benzamide trifluoroacetate, for example
09/29/2009US7595316 2-(1-Cyclopentylpiperidin-4-yloxy)-5-(4-cyanophenyl)pyrimidine, for example; exhibits histamine receptor H3 antagonist or inverse agonist activity and is useful for the treatment and/or prevention of obesity, diabetes, hormonal secretion abnormality, sleep disorders
09/29/2009US7595309 For therapy of bacterial infections and neoplasms,
09/29/2009CA2550372C Alpha-hydroxy amides as bradykinin antagonists or inverse agonists
09/29/2009CA2375670C 5-phenyl-pyrimidine derivatives
09/29/2009CA2349330C Nitrogen containing heterobicycles as factor xa inhibitors
09/29/2009CA2334923C Aryl substituted olefinic amines and their use as cholinergic receptors agonists
09/29/2009CA2328280C Thienopyrimidines
09/29/2009CA2311922C Thienopyrimidines
09/24/2009WO2009117080A1 Quinazoline derivatives as raf kinase modulators and methods of use thereof
09/24/2009WO2009115587A1 Regioselective preparation of substituted pyrimidines
09/24/2009WO2009115583A1 Regioselective preparation of substituted pyrimidines
09/24/2009WO2009083608A9 Quinazolines and related heterocyclic compounds, and their therapeutic use
09/24/2009WO2009057139A3 Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents
09/24/2009WO2009032668A3 2 -biphenylamino-4 -aminopyrimidine derivatives as kinase inhibitors
09/24/2009WO2009005674A3 Novel hiv reverse transcriptase inhibitors
09/24/2009US20090240054 Rosuvastatin calcium with a low salt content
09/24/2009US20090240053 2-(4-(1-methyl-4-piperidinoxy)benzylamino)-2-methyl-propanamide; nervous system disorders; analgesics; anticonvulsants; sodium channel moderators; antidepressants, antiarrhythmics and for the treatment or prevention of diabetic neuropathy
09/24/2009US20090240027 Intermediates for macrocyclic compounds
09/24/2009US20090239841 Diaryl Ureas as CB1 Antagonists
09/24/2009US20090239829 Thioaryl substituted inhibitors of zinc proteases and their use
09/24/2009US20090239811 Polycationic compounds and uses thereof
09/24/2009CA2755235A1 Nucleotide analogues with quaternary carbon stereogenic centers and methods of use
09/24/2009CA2718892A1 Selective preparation of substituted pyrimidines
09/24/2009CA2718858A1 Selective synthesis of substituted pyrimidines
09/24/2009CA2718123A1 Quinazoline derivatives as raf kinase modulators and methods of use thereof
09/23/2009EP2103601A1 Process for production of phenylalanine derivatives having quinazolinedione skeletons and intermediates for the production
09/23/2009EP2102199A1 Antibacterial polycyclic urea compounds
09/23/2009EP2102174A1 Process for the preparation of substituted cynophenoxy-pyrimidinyloxy-phenyl acrylate derivatives
09/23/2009EP2102173A1 Pyrimidyl derivatives as protein kinase inhibitors
09/23/2009EP2102172A1 Synthesis of 4-amino-pyrimidines
09/23/2009EP2101986A1 Dithiolene metal complex colorless ir absorbers
09/23/2009EP2101777A1 Composition for treating a pulmonary hypertension
09/23/2009CN101541767A Pyrimidines and their use as CXCR2 receptor antagonists
09/23/2009CN101541766A Pyrimidyl derivatives as protein kinase inhibitors
09/23/2009CN101541765A 3-piperidin-4-yl-indole ORL-1 receptor modulators
09/23/2009CN101541764A Pyrimidylmethyl-sulfonamide compounds useful as fungicides and against arthropods
09/23/2009CN101538254A Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
09/23/2009CN101538247A Alkaloid compound and preparation method thereof
09/23/2009CN101538246A Pyrimidine amide compounds as pgds inhibitors
09/23/2009CN101538230A Beta-amino ketones compound with anti-diabetic activity
09/22/2009US7592452 Reacting an aryl or heteroaryl halide with a cyanide donor,potassium hexacyanoferrate(II) or (III), in the presence of a copper compound and a 1-alkyl imidazole as a catalyst stabilizer); nontoxic; industrial scale; cost efficiency; chemical intermediates for agrochemicals and pharmaceuticals
09/22/2009US7592450 used to inhibit proliferative conditions, such as cancer and psoriasis, with improved bioavailability and stability
09/22/2009US7592446 Synthesis of selenium-derivatized nucleosides, nucleotides, phosphoramidites, triphosphates and nucleic acids
09/22/2009US7592349 Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors
09/22/2009US7592348 Heterocyclic aspartyl protease inhibitors
09/22/2009US7592337 Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5
09/22/2009US7592177 Compositions and methods for inducing cell dedifferentiation
09/22/2009CA2398274C Adenosine receptor modulators
09/17/2009WO2009114575A1 Tricyclic spiro pyrimidine derivatives as histamine h4 ligand
09/17/2009WO2009113320A1 Mmp inhibitor
09/17/2009WO2009112691A2 Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof
09/17/2009WO2009112490A1 Sulfonamides as zap-70 inhibitors
09/17/2009WO2009112461A1 Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors
09/17/2009WO2009111943A1 The compounds as the estrogen related receptors modulators and the uses thereof
09/17/2009WO2009111893A1 Substituted pyrimidine compounds and their use as ifnar mediators
09/17/2009US20090234119 Pyrimidinium cation and fluoroalkylsulfonate or fluoroalkylsulfonimide anions; solvents and catalysts
09/17/2009US20090233949 Isoserine derivatives for use as coagulation factor ixa inhibitors
09/17/2009US20090233924 Quinazoline derivatives
09/17/2009US20090233904 Macrocyclic Spiro Pyrimidine Derivatives
09/17/2009CA2750859A1 The compounds as the estrogen related receptors modulators and the uses thereof
09/17/2009CA2718241A1 Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors
09/17/2009CA2717529A1 Sulfonamides as zap-70 inhibitors
09/17/2009CA2713367A1 Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof
09/16/2009EP2100881A1 Pyrimidyl- or pyridinylaminobenzoic acid derivatives
09/16/2009EP2100507A1 Substance capable of inhibiting cytokinin signaling
09/16/2009EP2099772A2 Hydrates of erlotinib hydrochloride
09/16/2009EP2099771A1 Pyrimidine kinase inhibitors
1 ... 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 ... 427